Philips, NL0000009538

Philips stock: Citi lifts price target to EUR 26.50

Published on 11/20/2026 at 11:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Philips stock drew a higher target from Citi, while the bank kept its Neutral rating. The move adds a fresh analyst signal for investors.

Citi raises target while retaining Neutral

  • Citi analyst Veronika Dubajova lifted the Philips price target while keeping a Neutral rating.
  • The target change follows Philips' third-quarter outlook reaffirmation earlier in November.
  • Philips' healthcare technology portfolio remains the central investor focus ahead of its next company update.
Philips, NL0000009538, Illustration mit AI erstellt.

On November 18, 2026, Markets Insider, citing TipRanks and TheFly, reported that Citi analyst Veronika Dubajova raised Philips' price target from 26.00 euros to 26.50 euros and retained a Neutral rating.

Philips stock traded at 26.70 euros on Lang & Schwarz at 11:32 CET on Friday, November 20, 2026, 0.26 percent below the Xetra close of Thursday, November 19, 2026. The current quotation was above Citi's revised target, leaving the analyst's published valuation below the observed market price.

Analyst view follows third-quarter update

The target change came after Philips reported its third-quarter results on November 3 and reiterated its full-year outlook. The company said comparable sales growth should remain between 3 percent and 4.5 percent, while adjusted EBITA margin was expected at 13.5 percent to 14 percent. Philips also continued to target free cash flow of 1.5 billion euros to 1.7 billion euros for 2026.

The third-quarter release highlighted stronger order intake, margin expansion and progress on productivity. For investors, the Citi action adds a current valuation signal to a stock story shaped by execution in health technology, the Respironics legal overhang and the company's ability to convert its order book into profitable growth.

What investors should watch next

The next catalysts are updates on Philips' operational performance, the development of its health technology software and imaging portfolio, and further news on Respironics-related proceedings. Investors will also weigh whether the company's reiterated outlook remains achievable as it moves through the final part of 2026.

Koninklijke Philips N.V.

  • Company: Koninklijke Philips N.V.
  • ISIN: NL0000009538
  • Xetra symbol: PHI1.DE
  • Lang & Schwarz quote: 26.70 euros at 11:32 CET on November 20, 2026
  • Xetra close: 26.77 euros on November 19, 2026
  • Analyst: Citi, Neutral

The Dutch market backdrop can be followed through the AEX 25.

More news and analyses on Philips stock

Disclaimer...
en | NL0000009538 | PHILIPS | boerse | 70539642 | bgmi